MAEA and cancer: In the long term, based on preclinical evidence that EMP targeting might also enhance natural cancer immunosurveillance in a cancer preventive setting, it would be of great interest to also evaluate the efficacy of several drug candidates mentioned above in Table 1 in chemoprevention.